BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30613352)

  • 1. Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase
    Shapovalova M; Davydova J; Henzler C; Daniel M; Dehm SM; Warlick CA; LeBeau AM
    Oncotarget; 2018 Nov; 9(94):36693-36704. PubMed ID: 30613352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of alpha-methylacyl-CoA racemase by miR-138 via up-regulation of β-catenin in prostate cancer cells.
    Erdmann K; Kaulke K; Rieger C; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2201-2210. PubMed ID: 28741117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning and preliminary analysis of the human alpha-methylacyl-CoA racemase promoter.
    Chen W; Wu W; Zhao J; Yu C; Liu W; Jiang A; Zhang J
    Mol Biol Rep; 2009 Mar; 36(3):423-30. PubMed ID: 18080842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
    Zha S; Isaacs WB
    Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
    Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
    Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer.
    Shapovalova M; Davydova J; Henzler C; Daniel M; Dehm SM; Warlick CA; LeBeau AM
    Oncotarget; 2019 Aug; 10(47):4920. PubMed ID: 31448058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 2-arylthiopropanoyl-CoA inhibitors of α-methylacyl-CoA racemase 1A (AMACR; P504S) as potential anti-prostate cancer agents.
    Yevglevskis M; Nathubhai A; Wadda K; Lee GL; Al-Rawi S; Jiao T; Mitchell PJ; James TD; Threadgill MD; Woodman TJ; Lloyd MD
    Bioorg Chem; 2019 Nov; 92():103263. PubMed ID: 31536953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.
    Zha S; Ferdinandusse S; Denis S; Wanders RJ; Ewing CM; Luo J; De Marzo AM; Isaacs WB
    Cancer Res; 2003 Nov; 63(21):7365-76. PubMed ID: 14612535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.
    Zhou M; Jiang Z; Epstein JI
    Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined α-methylacyl-CoA racemase inhibition and docetaxel treatment reduce cell proliferation and decrease expression of heat shock protein 27 in androgen receptor-variant-7-positive prostate cancer cells.
    Yoshizawa A; Takahara K; Saruta M; Zennami K; Nukaya T; Fukaya K; Ichino M; Fukami N; Niimi A; Sasaki H; Kusaka M; Suzuki M; Sumitomo M; Shiroki R
    Prostate Int; 2021 Mar; 9(1):18-24. PubMed ID: 33912510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
    Rubin MA; Zhou M; Dhanasekaran SM; Varambally S; Barrette TR; Sanda MG; Pienta KJ; Ghosh D; Chinnaiyan AM
    JAMA; 2002 Apr; 287(13):1662-70. PubMed ID: 11926890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
    Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of a-methylacyl COA racemase in prostate cancer of the Iranian population.
    Taheri D; Roohani E; Izadpanahi MH; Dolatkhah S; Aghaaliakbari F; Daneshpajouhnejad P; Gharaati MR; Mazdak H; Fesharakizadeh S; Beinabadi Y; Kazemi R; Rahbar M
    J Res Med Sci; 2021; 26():46. PubMed ID: 34484378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate Cancer Diagnosis Using Urine Sediment Analysis-Based α-Methylacyl-CoA Racemase Score: A Single-Center Experience.
    Ji J; Chen X; Xu Y; Cao Z; Xu H; Kong C; Wang F; Sun Y
    Cancer Control; 2019; 26(1):1073274819887697. PubMed ID: 31793344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements.
    Rubin MA; Zerkowski MP; Camp RL; Kuefer R; Hofer MD; Chinnaiyan AM; Rimm DL
    Am J Pathol; 2004 Mar; 164(3):831-40. PubMed ID: 14982837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-Methylacyl-CoA Racemase (AMACR), a Potential New Biomarker for Glioblastoma.
    Lee H; Kim M; Kim SH; Tran Q; Kong G; Kim C; Kwon SH; Park J; Park JB; Park S; Park J
    Front Oncol; 2020; 10():550673. PubMed ID: 33154941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
    Wang J; Weng J; Cai Y; Penland R; Liu M; Ittmann M
    Prostate; 2006 Jun; 66(8):847-57. PubMed ID: 16491480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?
    Zhou M; Aydin H; Kanane H; Epstein JI
    Am J Surg Pathol; 2004 Feb; 28(2):239-43. PubMed ID: 15043314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death.
    Rubin MA; Bismar TA; Andrén O; Mucci L; Kim R; Shen R; Ghosh D; Wei JT; Chinnaiyan AM; Adami HO; Kantoff PW; Johansson JE
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1424-32. PubMed ID: 15941951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Alpha-Methylacyl-CoA Racemase (AMACR), a Biomarker of Prostate Cancer, in Patient Blood Samples Using a Nanoparticle Electrochemical Biosensor.
    Lin PY; Cheng KL; McGuffin-Cawley JD; Shieu FS; Samia AC; Gupta S; Cooney M; Thompson CL; Liu CC
    Biosensors (Basel); 2012 Sep; 2(4):377-87. PubMed ID: 25586028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.